Harpoon Therapeutics, Inc. SEC Filings

Filed On	Filing
21 Mar 2024	15-12G
18 Mar 2024	SC 13G
13 Mar 2024	SC 13D/A
11 Mar 2024	EFFECT
11 Mar 2024	EFFECT
11 Mar 2024	EFFECT
11 Mar 2024	Form 4: New Leaf Biopharma Opportunities II, L.p., Director and 6 others Returned 1,859,169 shares to the issuer · Returned 10,000 shares to the issuer · Disposed of 1,071,180 Common Stock Warrant (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Silvernail Lauren P, Director Returned 5,000 shares to the issuer · Disposed of 4,333 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Hunt Ronald, Director Received 424 shares as a grant or award · Returned 1,872,393 shares to the issuer · Returned 10,000 shares to the issuer · 2 more
11 Mar 2024	Form 4: Walker Luke Nathaniel, Chief Medical Officer Returned 135,000 shares to the issuer · Disposed of 40,500 Employee Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Myers Scott Dunseth, Director Returned 22,665 shares to the issuer · Disposed of 6,633 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Chin Mark, Director Received 424 shares as a grant or award · Returned 13,224 shares to the issuer · Disposed of 8,563 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Drachman Jonathan G, Director Received 415 shares as a grant or award · Returned 5,415 shares to the issuer · Disposed of 8,847 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Robbins Andrew R, Director Returned 5,000 shares to the issuer · Disposed of 3,316 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Lanza Frank J, Principal Fin. & Acctng Ofc. Returned 18,734 shares to the issuer · Disposed of 15,142 Employee Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Eastland Julia Marie, Director Received 31,250 shares as a grant or award · Returned 269,381 shares to the issuer · Disposed of 43,524 Employee Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Bailes Joseph S, Director Returned 5,000 shares to the issuer · Disposed of 6,458 Director Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Bucher James B, Chief Legal Officer Disposed of 110,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)
11 Mar 2024	Form 4: Merck & Co., Inc., 10% owner and 1 other Bought 21,397,205 shares ($492M)
11 Mar 2024	SC 13D/A

Comments